about
sameAs
ASB4 is a hydroxylation substrate of FIH and promotes vascular differentiation via an oxygen-dependent mechanismAn intact NEDD8 pathway is required for Cullin-dependent ubiquitylation in mammalian cells.Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor.HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylationHypoxia-inducible factor-1alpha polymorphisms and TSC1/2 mutations are complementary in head and neck cancersVHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma.Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP.LXY6090 - a novel manassantin A derivative - limits breast cancer growth through hypoxia-inducible factor-1 inhibitionHIF-1alpha is essential for myeloid cell-mediated inflammationMechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity.Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in miceAlterations in the muscle-to-capillary interface in patients with different degrees of chronic obstructive pulmonary disease.Amplification and overexpression of Elongin C gene discovered in prostate cancer by cDNA microarrays.Diverse effects of mutations in exon II of the von Hippel-Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activity.Expression of angiopoietins in renal epithelial and clear cell carcinoma cells: regulation by hypoxia and participation in angiogenesis.Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells.Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer.The archipelago ubiquitin ligase subunit acts in target tissue to restrict tracheal terminal cell branching and hypoxic-induced gene expression.VEGFR-1 Expression Relates to Fuhrman Nuclear Grade of Clear Cell Renal Cell CarcinomaHypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1The Roles of Angiogenesis in Malignant Melanoma: Trends in Basic Science Research over the Last 100 Years.Association of Hypoxia-Inducible Factor-2 Alpha Gene Polymorphisms with the Risk of Hepatitis B Virus-Related Liver Disease in Guangxi Chinese: A Case-Control Study.Protease-activated receptors in cancer: A systematic review.Beluga whale pVHL enhances HIF-2α activity via inducing HIF-2α proteasomal degradation under hypoxiaRegulation of gene expression by hypoxia: integration of the HIF-transduced hypoxic signal at the hypoxia-responsive elementTivozanib in the treatment of renal cell carcinoma.Role of NADH Dehydrogenase (Ubiquinone) 1 Alpha Subcomplex 4-Like 2 in Clear Cell Renal Cell CarcinomaTranscriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer.Genomic analysis of pilocytic astrocytomas at 0.97 Mb resolution shows an increasing tendency toward chromosomal copy number change with age.Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines.Structural alterations of skeletal muscle in copd.Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases.Renal cell carcinoma development and miRNAs: a possible link to the EGFR pathway.Regression of solid tumors by engineered overexpression of von Hippel-Lindau tumor suppressor protein and antisense hypoxia-inducible factor-1alpha.GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism.The E2 ubiquitin conjugase Rad6 is required for the ArgR/Mcm1 repression of ARG1 transcription.The Hsp70 and TRiC/CCT chaperone systems cooperate in vivo to assemble the von Hippel-Lindau tumor suppressor complex.Manganese superoxide dismutase suppresses hypoxic induction of hypoxia-inducible factor-1alpha and vascular endothelial growth factor.Expression of Von Hippel - Lindau (VHL) gene mutation in diagnosed cases of renal cell carcinoma.
P2860
Q24320200-92B9F906-C57B-45D9-B70B-E9389C945B51Q24522556-9ED63768-476D-4B60-9B99-FB5DF7A179AAQ24536055-6D9B0F0C-40FC-4674-B9FB-DC4288132522Q24555773-740CE961-0C07-4904-8438-5B2C34437EF7Q25255621-C1FEAB1A-85B8-41EC-9ECA-B2886377E265Q27824781-D851616B-D243-43F5-BD6B-DE0E55FEE175Q28213770-D7FF9ADE-9175-45E1-B396-8D293B9ED176Q28828209-2EF0A3CA-4F8F-4459-BE05-6191FD188CA0Q29617581-AABCC1F1-5A41-4C53-B845-CFB7B1BE3D2BQ33925065-E52E5208-2B04-407A-B4D3-DAAC33CF287DQ34009762-2356C67F-9D8A-4D8F-8072-B83F3239493FQ34031244-24AB54AE-520A-4A70-AE5F-EFC09753C058Q34127887-65B57F01-C70A-4E9E-8653-CCAF721475A0Q34323668-BA3696F1-61F6-402E-9ACD-718D61F53304Q34327105-E3B1ED80-62C5-4859-80A4-631DDC7A6035Q34536583-337E3730-7A3A-4BCA-81DF-E978C168E65FQ34558244-252E48DA-4080-49DD-BCC5-E95232A0E224Q34607947-1ED386DD-4FDC-497F-9FB8-32515D5CF142Q35332976-B0D8B539-96FC-4C8A-A2C6-756660CEE0C5Q35882401-C9425C83-80F9-4F27-86F6-C2A53F5E8769Q36037600-003E65A6-068B-4DED-8345-03CD2BD2B409Q36069245-A4DBD773-74F2-45A3-B50A-D231A6A7AC39Q36121203-1BA91B9F-0FE0-401F-A3E2-F21D938EF872Q36274373-CD7B14B1-5210-47C5-A629-01BBF614E28CQ36876347-5B5C1F4A-34D8-4F69-BB99-5983E6D1AA33Q36933605-E6858E72-7588-4BDE-96EF-8CE959B241C0Q36963431-9293DAF7-75CF-4B66-8D38-EF9AC02D0C62Q37161440-A6B5AA32-D793-4EC4-B5C0-4ACBE81114E5Q37295258-D066952C-6884-4B75-A18B-EEE3E61B4EB6Q37386688-95670C14-2D55-4929-81F8-1E804532DDE4Q37600922-422F7A75-1592-4052-B55B-6B7D67E35610Q37644954-D7E0AFC5-7129-412B-AB7A-9F70D1CA242FQ38154554-865A975B-F88C-4D95-A7F3-B93EF9094EBFQ38160090-CC96ADBA-E418-4A8F-A654-4C6476E4A31FQ38348490-85861AED-3832-4CF9-AC11-A68CBBFB82D7Q38962203-A87468FC-517A-4E8E-B442-0A64AD978ED0Q39406784-38FC7DB4-1673-487D-8FEE-C023B6B0C8F0Q39745880-BCBB4CF7-FBB5-4DB3-96EA-C6006FFB16E3Q40371724-8AECE322-3A75-475A-8F6A-2B99CE2206A4Q42768997-08677D94-2620-41E3-87DD-72A0253C4FE4
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The von Hippel-Lindau tumor suppressor gene
@ast
The von Hippel-Lindau tumor suppressor gene
@en
The von Hippel-Lindau tumor suppressor gene
@nl
type
label
The von Hippel-Lindau tumor suppressor gene
@ast
The von Hippel-Lindau tumor suppressor gene
@en
The von Hippel-Lindau tumor suppressor gene
@nl
prefLabel
The von Hippel-Lindau tumor suppressor gene
@ast
The von Hippel-Lindau tumor suppressor gene
@en
The von Hippel-Lindau tumor suppressor gene
@nl
P3181
P356
P1476
The von Hippel-Lindau tumor suppressor gene
@en
P2093
P304
P3181
P356
10.1006/EXCR.2000.5139
P407
P577
2001-03-10T00:00:00Z